{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:02:49Z","timestamp":1793116969913,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:00:00Z","timestamp":1552867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002973","name":"Daiichi Sankyo Company, Limited","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jiac.2019.03.008","type":"journal-article","created":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T09:04:32Z","timestamp":1554282272000},"page":"594-604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Investigation of the susceptibility trends in Japan to fluoroquinolones and other antimicrobial agents in a nationwide collection of clinical isolates: A longitudinal analysis from 1994 to 2016"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6200-6163","authenticated-orcid":false,"given":"Kazuhiro","family":"Tateda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hinako","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keizo","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2019.03.008_bib2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/1060028014556879","article-title":"Vancomycin-resistant enterococcal bacteremia pharmacotherapy","volume":"49","author":"Patel","year":"2015","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jiac.2019.03.008_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141765","article-title":"Trends in Extended spectrum beta-lactamase (ESBL) producing Enterobacteriaceae and ESBL genes in a Dutch Teaching Hospital, measured in 5 yearly point prevalence surveys (2010-2014)","author":"Willemsen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jiac.2019.03.008_bib4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3947\/ic.2015.47.2.81","article-title":"Epidemiology and characteristics of metallo-\u03b2-lactamase-producing Pseudomonas aeruginosa","volume":"47","author":"Hong","year":"2015","journal-title":"Infect Chemother"},{"key":"10.1016\/j.jiac.2019.03.008_bib5","doi-asserted-by":"crossref","first-page":"30461","DOI":"10.2807\/1560-7917.ES.2017.22.6.30461","article-title":"Trends in carbapenemase-producing Enterobacteriaceae, France, 2012 to 2014","volume":"22","author":"Dortet","year":"2017","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jiac.2019.03.008_bib6","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.cmi.2014.12.025","article-title":"Appropriate antimicrobial therapy in the era of multidrug-resistant human pathogens","volume":"21","author":"Pogue","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2019.03.008_bib7","first-page":"491","article-title":"Emergence of antimicrobial resistance among Acinetobacter species: a global threat","volume":"22","author":"Clark","year":"2016","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.jiac.2019.03.008_bib8","series-title":"National action plan on antimicrobial resistance (AMR) 2016-2020","year":"2016"},{"key":"10.1016\/j.jiac.2019.03.008_bib9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.diagmicrobio.2005.02.009","article-title":"Investigation of the susceptibility trends in Japan to fluoroquinolones and other antimicrobial agents in a nationwide collection of clinical isolates: a longitudinal analysis from 1994 to 2002","volume":"52","author":"Yamaguchi","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2019.03.008_bib10","series-title":"M07: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","year":"2015"},{"key":"10.1016\/j.jiac.2019.03.008_bib11","series-title":"M100: Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute","year":"2017"},{"key":"10.1016\/j.jiac.2019.03.008_bib12","series-title":"Breakpoint tables for interpretation of MICs and zone diameters Version 7.1","year":"2017"},{"key":"10.1016\/j.jiac.2019.03.008_bib13","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1001\/jama.290.22.2976","article-title":"Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection","volume":"290","author":"Naimi","year":"2003","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.jiac.2019.03.008_bib14","first-page":"53","article-title":"Direct sequencing of DNA produced in a polymerase chain reaction","volume":"167","author":"Gerischer","year":"2001","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jiac.2019.03.008_bib15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/cmb.2012.0021","article-title":"SPAdes: A new genome assembly algorithm and its applications to single-cell sequencing","volume":"19","author":"Bankevich","year":"2012","journal-title":"J\u00a0Comput Biol"},{"key":"10.1016\/j.jiac.2019.03.008_bib16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","article-title":"Basic local alignment search tool","volume":"215","author":"Altschul","year":"1990","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.jiac.2019.03.008_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkx349","article-title":"Daptomycin","volume":"73","author":"Heidary","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2019.03.008_bib18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s10156-012-0379-6","article-title":"The emerging ST8 methicillin-resistant Staphylococcus aureus clone in the community in Japan: associated infections, genetic diversity, and comparative genomics","volume":"18","author":"Iwao","year":"2012","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2019.03.008_bib19","first-page":"416","article-title":"Clinical aspects of infection with methicillin-resistant Staphylococcus aureus USA300 strain, generally regarded as community-acquired, in Japan","volume":"66","author":"Nakamura","year":"2013","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jiac.2019.03.008_bib20","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1089\/mdr.2014.0153","article-title":"Molecular characterization of community-associated methicillin-resistant Staphylococcus aureus isolated from skin and pus samples of outpatients in Japan","volume":"21","author":"Yamaguchi","year":"2015","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.jiac.2019.03.008_bib21","doi-asserted-by":"crossref","first-page":"a025320","DOI":"10.1101\/cshperspect.a025320","article-title":"Topoisomerase inhibitors: Fluoroquinolone mechanisms of action and resistance","volume":"6","author":"Hooper","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jiac.2019.03.008_bib22","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1097\/INF.0000000000000776","article-title":"Impact of the seven-valent pneumococcal conjugate vaccine on acute otitis media in Japanese children: Emergence of Serotype 15A Multidrug-resistant Streptococcus pneumoniae in Middle Ear Fluid Isolates","volume":"34","author":"Ozawa","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jiac.2019.03.008_bib23","doi-asserted-by":"crossref","first-page":"30423","DOI":"10.2807\/1560-7917.ES.2016.21.50.30423","article-title":"Rise of multidrug-resistant non-vaccine serotype 15A Streptococcus pneumoniae in the United Kingdom, 2001 to 2014","volume":"21","author":"Sheppard","year":"2016","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jiac.2019.03.008_bib24","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1586\/14787210.2015.1023292","article-title":"Macrolide-resistant Streptococcus pyogenes: prevalence and treatment strategies","volume":"13","author":"Silva-Costa","year":"2015","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jiac.2019.03.008_bib25","doi-asserted-by":"crossref","first-page":"e00851","DOI":"10.1128\/AAC.00851-18","article-title":"Multiclonal expansion and high prevalence of \u03b2-lactamase-negative Haemophilus influenzae with high-level ampicillin resistance in Japan and susceptibility to quinolones","volume":"62","author":"Honda","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2019.03.008_bib26","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.ijporl.2010.05.008","article-title":"Clonal spread of beta-lactamase-producing amoxicillin-clavulanate-resistant (BLPACR) strains of non-typeable Haemophilus influenzae among young children attending a day care in Japan","volume":"74","author":"Ito","year":"2010","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.jiac.2019.03.008_bib27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.15171\/apb.2015.047","article-title":"Carriage of class 1 and 2 integrons in quinolone, extended-spectrum-\u03b2-lactamase-producing and multi drug resistant E.\u00a0coli and K.\u00a0pneumoniae: high burden of antibiotic resistance","volume":"5","author":"Shams","year":"2015","journal-title":"Adv Pharma Bull"},{"key":"10.1016\/j.jiac.2019.03.008_bib28","doi-asserted-by":"crossref","first-page":"659","DOI":"10.4103\/0366-6999.201601","article-title":"Trends in drug resistance of Acinetobacter baumannii over a 10-year-period: Nationwide data from the China surveillance of antimicrobial resistance program","volume":"130","author":"Gao","year":"2017","journal-title":"Chin Med J"},{"key":"10.1016\/j.jiac.2019.03.008_bib29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.7883\/yoken.JJID.2015.049","article-title":"An epidemiological investigation of a nosocomial outbreak of multidrug-resistant Acinetobacter baumannii in a critical care center in Japan, 2011\u20132012","volume":"69","author":"Ushizawa","year":"2016","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.jiac.2019.03.008_bib30","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jiac.2015.03.005","article-title":"Nationwide surveillance of 6 otorhinolaryngological infectious diseases and antimicrobial susceptibility pattern in the isolated pathogens in Japan","volume":"21","author":"Suzuki","year":"2015","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2019.03.008_bib31","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jiac.2017.03.010","article-title":"Antimicrobial susceptibility of pathogens isolated from surgical site infections in Japan: Comparison of data from nationwide surveillance studies conducted in 2010 and 2014-2015","volume":"23","author":"Takesue","year":"2017","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2019.03.008_bib32","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jiac.2017.05.006","article-title":"The first nationwide surveillance of antibacterial susceptibility patterns of pathogens isolated from skin and soft-tissue infections in dermatology departments in Japan","volume":"23","author":"Watanabe","year":"2017","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2019.03.008_bib33","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jiac.2017.05.010","volume":"23","author":"Yanagihara","year":"2017","journal-title":"J\u00a0Infect Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X1930073X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X1930073X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:59:22Z","timestamp":1761159562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X1930073X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1341321X1930073X"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2019.03.008","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of the susceptibility trends in Japan to fluoroquinolones and other antimicrobial agents in a nationwide collection of clinical isolates: A longitudinal analysis from 1994 to 2016","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2019.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}